The Challenges of CMC in Cell and Gene Therapies

Safety is one of the most important aspects of drug development. The need for a drug to be efficacious, consistent and non-harmful to humans is vital for its success. And where a treatment is new, highly variable, and can involve...

4 weeks ago
Bioprocess,CGT,Biomanufacturing,CMC,Regulatory Affairs,News

The Challenges of CMC in Cell and Gene Therapies

Safety is one of the most important aspects of drug development. The need for a drug to be efficacious, consistent and non-harmful to humans is vital for its success. And where a treatment is new, highly variable, and can involve...

4 weeks ago

Trending Innovations in Cold Chain Processes

As is increasingly known in the pharmaceutical industry, the rise in both trial costs and drug failures has seen a corresponding increase in the need for tight regulations and stricter procedures, to ensure the few successes are not further compromised....

4 months ago
Bioprocess,Biomanufacturing,CMC,News

Trending Innovations in Cold Chain Processes

As is increasingly known in the pharmaceutical industry, the rise in both trial costs and drug failures has seen a corresponding increase in the need for tight regulations and stricter procedures, to ensure the few successes are not further compromised....

4 months ago

Single-Use Technologies: Challenges and Solutions

Since their increased popularisation from the mid-1990s, single- and limited-use technologies (collectively SUTs) have changed the field of biomanufacturing. This has been driven partly by the heavy growth of the pharma market, from $162 billion in 2014 to around $270...

8 months ago
Bioprocess,Biomanufacturing,CMC,News

Single-Use Technologies: Challenges and Solutions

Since their increased popularisation from the mid-1990s, single- and limited-use technologies (collectively SUTs) have changed the field of biomanufacturing. This has been driven partly by the heavy growth of the pharma market, from $162 billion in 2014 to around $270...

8 months ago